Stocks and InvestingStocks and Investing
Thu, February 29, 2024
Wed, February 28, 2024

Balaji Prasad Maintained (TARS) at Buy with Increased Target to $50 on, Feb 28th, 2024


Published on 2024-10-28 09:17:53 - WOPRAI, Balaji Prasad
  Print publication without navigation


Balaji Prasad of Barclays, Maintained "Tarsus Pharmaceuticals, Inc." (TARS) at Buy with Increased Target from $40 to $50 on, Feb 28th, 2024.

Balaji has made no other calls on TARS in the last 4 months.



There is 1 other peer that has a rating on TARS. Out of the 1 peers that are also analyzing TARS, all agrees with Balaji's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $19 on, Monday, November 20th, 2023